Alcon Inc.: Business Overview, Financials & Competitive Analysis
Alcon Inc. scores 7/10 on the AskCyborg Cyborg Score (Solid). Premium-valued surgical eye care leader with robust innovation momentum and strong cash generation, offset by tariff headwinds and moderating guidance. Alcon achieved 7% sales growth in 2025 with 2026 guidance calling for 5-7% sales growth and margin expansion, supported by strong product pipelines. However, tariffs are expected to have a.
What is Alcon Inc.'s industry? Alcon Inc. (alcon.com) operates in Medical Devices - Ophthalmology. AskCyborg classifies Alcon Inc. under Medical Devices - Ophthalmology in its company registry.
Alcon is the global leader in eye care with a heritage spanning over 75 years, offering the broadest portfolio of products to enhance sight and improve people's lives. The company grew 2025 sales to $10.3B, serving me...
Cyborg Score thesis
Premium-valued surgical eye care leader with robust innovation momentum and strong cash generation, offset by tariff headwinds...
Read the full analyst-debate transcript →Get the Latest Alcon Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeAlcon Inc. Overview
Pro stress-test →Alcon is the global leader in eye care with a heritage spanning over 75 years, offering the broadest portfolio of products to enhance sight and improve people's lives. The company grew 2025 sales to $10.3B, serving medical professionals and patients across surgical and vision care segments.
Strategic Profile
Pro stress-test →Alcon develops and markets surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products through Surgical and Vision Care segments, with the Surgical segment offering implantable products, consumables and equipment for cataracts, vitreoretinal conditions, refractive errors, and glaucoma, while the Vision Care segment comprises contact lenses and ocular health products. The company successfully launched a wave of innovative new products that fueled sales acceleration in 2025.
Competitive Landscape
Pro stress-test →Alcon, headquartered in Geneva, Switzerland, is a global leader in eye care that spun off from Novartis in 2019 to operate independently. The company competes in large fragmented markets for surgical eye care equipment and contact lenses against diversified healthcare conglomerates and specialized ophthalmology players. Market leadership is driven by breadth of product portfolio, innovation velocity, and global distribution reach.
Industry Context
Alcon Inc. operates in Medical Devices - Ophthalmology.
Key facts
Founded: 1945 · Headquarters: Geneva, Switzerland · Employees: 25,940 · Revenue: $10.3B · Market cap: $32.6B